| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |